These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor. Author: Gong J, Xu W. Journal: Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659. Abstract: Oseltamivir phosphate (Tamiflu) is the only orally active anti-influenza drug that potently inhibit neuraminidase. The recent emergence of avian flu, especially the H5N1 type, makes the situation of Tamiflu supply and demand increasingly serious. Further optimization of the current commercial approach and exploration of new synthetic routes are urgent. Here, different synthetic strategies of oseltamivir phosphate are reviewed, including discovery and improved synthetic route from (-)-quinic acid or (-)-shikimic acid, new asymmetric synthesis via catalytic desymmetrization of a meso-aziridine (CDMA), Diels-Alder Reaction and from other available materials.[Abstract] [Full Text] [Related] [New Search]